PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
days to go:
Expired
investment:
£76,030
Actve is on a mission to change the way people connect with their favourite fitness creators. The company aspires to help creators earn an income and build a subscription business. Actve asserts that it caters to a variety of creator needs allowing them to live-stream their workouts, offer guided programs to customers, or use Actve's software to manage their clients. The company aims to become a contender in the digital fitness market that is projected to be worth £21 billion by 2022. It aims to launch its platform in September 2021. Actve will use the investment to develop its platform, hire key staff, build its user base, and work towards becoming an industry champion for fitness creators.
days to go:
Expired
investment:
£165,627
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
Crowd Cook was built to help Britains talented amateur cooks show the world just how good they really are and to supply retailers with extraordinary food from the crowd.
days to go:
Expired
investment:
£28,560
Positivitea is a range of teas based on the chakras. They are already stocked in over 80 locations throughout the UK and Europe including Urban Outfitters and Fenwick. The use of the proceeds raised will go towards expanding the team and getting Positivitea in more retail outlets and being used by more suppliers.
days to go:
Expired
investment:
£103,640
Peckwater Brands (PB) is a company engaged in the growing cloud kitchen/delivery business that runs virtual restaurant brands from the kitchens of existing restaurants. It argues that restaurants need to pay high street rents and staff wages no matter how many diners visit. Nearly 5,000 restaurants have closed in the UK since 2015 due to not being able to fulfil these tasks. PB aims to change this scenario. It helps restaurant partners use their existing staff and kitchen capacity better, and help keep struggling businesses running. The company received more than 10,000 customer orders through Deliveroo and Uber Eats. It witnessed more than £250,000 in customer sales since June 2020 and is spread across London, Manchester, Leeds, and Coventry. PB has launched four brands with four more in the pipeline. It will use the investment to get more partners, launch more brands, and acquire more customers.
days to go:
Expired
investment:
£232,208
A versatile spicy peanut chutney that can be used as a spread, marinade, dip or condiment. Kit's Peanut Chutney is homemade using natural ingredients, as well as being vegan nad gluten-free. The company is seeking investment mass produce their products and increase the number of stockists that list their range.
Currently, the products are stocked by nine independent retailers and new outlets are being added every day. To date, more than 600 jars have been sold. By increasing their production, they aim to lower the cost of their products whilst yielding a 73% gross profit margin per jar sold. Wholesaling will yield a gross profit margin of 44% per jar.
days to go:
Expired
investment:
£102,510
